Cargando…
Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats
BACKGROUND: Oxaliplatin is a platinum-based chemotherapy drug characterized by the development of acute and chronic peripheral neuropathies. The chronic neuropathy is a dose-limiting toxicity. We previously reported that repeated administration of oxaliplatin induced cold hyperalgesia in the early p...
Autores principales: | Mihara, Yuki, Egashira, Nobuaki, Sada, Hikaru, Kawashiri, Takehiro, Ushio, Soichiro, Yano, Takahisa, Ikesue, Hiroaki, Oishi, Ryozo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033350/ https://www.ncbi.nlm.nih.gov/pubmed/21247499 http://dx.doi.org/10.1186/1744-8069-7-8 |
Ejemplares similares
-
Inhibition of Ca(2+)/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
por: Shirahama, Masafumi, et al.
Publicado: (2012) -
L type Ca(2+ )channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats
por: Kawashiri, Takehiro, et al.
Publicado: (2012) -
Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015) -
Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
por: Yamamoto, Shota, et al.
Publicado: (2017) -
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)